2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)

Европейские рекомендации 2016 года по профилактике сердечно-сосудистых заболеваний в клинической практике
Giuseppe Mancia, Josep Redón, Oscar H. Franco, Stefan Agewall, Héctor Bueno, Eva Prescott, Marco Roffi, Victor Aboyans, Gregory Y.H. Lip, Alexander Niessner, Massimo Francesco Piepoli, Stephan Windecker, Carlos Brotons, Dimitrios J. Richter, Maja‐Lisa Løchen, José Luis Zamorano, Donna Fitzsimons, Piotr P. Ponikowski, Paulus F. Kirchhof, Arno Wilhelmus Hoes, Norbert Bachl, Richard F. Hobbs, Christi Deaton, Authors/Task Force Members, Guy De Backer, Ian D. Graham, Joep Perk, Alberico Luigi Catapano, Olov Wiklund, Catriona Sian Jennings, W. M. Monique Verschuren, François Mach, Yvo M. Smulders, Bernard Cosyns, Naveed A. Sattar, Ineke van Dis, Christian Albus, Miles Fisher, Pedro Manuel Marques-Vidal, Lars Rydén, Monica Tiberi, Leslie Cho, Kornelia Kotseva, Johan DE SUTTER, Marie Therese Cooney, Ugo Corrà, Michael Stephen Hall, Herbert Löllgen, H. Bart van der Worp, Yvo Michiel Smulders, Scipione Carerj, Guillaume Turc, Borut Jug, Alessandro Mezzani, Document Reviewers:, Additional Contributor: Simone Binno (Italy), JOHN M. R. COX, Günther Egidi, Maxime Guenoun, Franz Martin Bermudo, Bernhard Rauch, Adrienne Stauder, H. Bart van der Worp
2016-06-27

cardiovascular disease preventioncardiovascular risk factorsclinical practice guidelinescoronary artery diseasehealthy lifestyle promotion
... ... Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the population level or targeted at an individual, that are aimed at eliminating or minimizing the impact of CVDs and their related disabilities.1 CVD remains a leading cause of morbidity and mortality, despite improvements in outcomes. Age-adjusted coronary artery disease (CAD) mortality has declined since the 1980s, particularly in high-income regions.2 CAD rates are now less than half what they were in the early 1980s in many countries in Europe, due to preventive measures including the success of smoking legislation. However, inequalities between countries persist and many risk factors, particularly obesity3 and diabetes mellitus (DM),4 have been increasing substantially. If prevention was practised as instructed it would markedly reduce the prevalence of CVD. It is thus not only prevailing risk factors that are of concern, but poor implementation of preventive measures as well.5,6 Prevention should be delivered (i) at the general population level by promoting healthy lifestyle behaviour7 and (ii) at the individual level, i.e. in those subjects at moderate to high risk of CVD or patients with established CVD, by tackling unhealthy lifestyles (e.g. poor-quality diet, physical inactivity, smoking) and by optimising risk factors. Prevention is effective: the elimination of health risk behaviours would make it possible to prevent at least 80% of CVDs and even 40% of cancers.8,9
1
Age-adjusted coronary artery disease mortality has declined since the 1980s, with rates below half of early-1980s levels in many European countries.
2
Cardiovascular disease prevention requires coordinated population-level and individual-level actions to reduce disease burden and disability.
3
Eliminating unhealthy risk behaviours could prevent at least 80% of cardiovascular diseases and 40% of cancers, but implementation of recommended prevention remains inadequate.
4
Obesity and diabetes mellitus are increasing substantially, highlighting continuing and emerging cardiovascular risk-factor challenges.
5
Smoking legislation and other preventive measures contributed substantially to declining coronary artery disease rates, although inequalities between European countries persist.

Clinical practice guidelines for cardiovascular disease prevention in Europe (2016)

coordinated population- and individual-level actions to eliminate or minimize cardiovascular disease and related disabilities, including lifestyle modification and optimization of risk factors

Publication Details
Publication Date
2016-06-27
Journal
Publisher
ISSN
Cited by
1447
Access Type
Author Information
Authors
Giuseppe Mancia
Josep Redón
Oscar H. Franco
Stefan Agewall
Héctor Bueno
Eva Prescott
Marco Roffi
Victor Aboyans
Gregory Y.H. Lip
Alexander Niessner
Massimo Francesco Piepoli
Stephan Windecker
Carlos Brotons
Dimitrios J. Richter
Maja‐Lisa Løchen
José Luis Zamorano
Donna Fitzsimons
Piotr P. Ponikowski
Paulus F. Kirchhof
Arno Wilhelmus Hoes
Norbert Bachl
Richard F. Hobbs
Christi Deaton
Authors/Task Force Members
Guy De Backer
Ian D. Graham
Joep Perk
Alberico Luigi Catapano
Olov Wiklund
Catriona Sian Jennings
W. M. Monique Verschuren
François Mach
Yvo M. Smulders
Bernard Cosyns
Naveed A. Sattar
Ineke van Dis
Christian Albus
Miles Fisher
Pedro Manuel Marques-Vidal
Lars Rydén
Monica Tiberi
Leslie Cho
Kornelia Kotseva
Johan DE SUTTER
Marie Therese Cooney
Ugo Corrà
Michael Stephen Hall
Herbert Löllgen
H. Bart van der Worp
Yvo Michiel Smulders
Scipione Carerj
Guillaume Turc
Borut Jug
Alessandro Mezzani
Document Reviewers:
Additional Contributor: Simone Binno (Italy)
JOHN M. R. COX
Günther Egidi
Maxime Guenoun
Franz Martin Bermudo
Bernhard Rauch
Adrienne Stauder
H. Bart van der Worp
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%